Document 0364
 DOCN  M9460364
 TI    Estimating the value of preventing a human immunodeficiency virus
       infection.
 DT    9408
 AU    Guinan ME; Farnham PG; Holtgrave DR; Office of HIV/AIDS, Centers for
       Disease Control and Prevention,; Atlanta, GA 30333.
 SO    Am J Prev Med. 1994 Jan-Feb;10(1):1-4. Unique Identifier : AIDSLINE
       MED/94226823
 AB    We estimated the medical cost savings for a case of human
       immunodeficiency virus (HIV) infection prevented. Using medical care
       cost estimates, assumptions concerning knowledge of serostatus, time
       spent in various stages of HIV disease, and a discount factor, we
       estimated the present value of future cost savings for a case of HIV
       prevented, which ranged from $56,000 to $80,000. Since this method
       excludes both indirect costs and direct costs other than medical care,
       these figures underestimate the true cost savings for a case of HIV
       prevented. However, the method may prove useful in assigning a
       systematic economic value to an HIV infection averted that can be used
       in cost-benefit analyses of HIV prevention interventions.
 DE    *Cost Savings  *Health Care Costs/STATISTICS & NUMER DATA  Human  HIV
       Infections/*ECONOMICS/PREVENTION & CONTROL  Time Factors  JOURNAL
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).